Heide, Timon;
Househam, Jacob;
Cresswell, George D;
Spiteri, Inmaculada;
Lynn, Claire;
Mossner, Maximilian;
Kimberley, Chris;
... Sottoriva, Andrea; + view all
(2022)
The co-evolution of the genome and epigenome in colorectal cancer.
Nature
10.1038/s41586-022-05202-1.
(In press).
Preview |
Text
Bridgewater_The co-evolution of the genome and epigenome in colorectal cancer_AOP.pdf - Published Version Download (6MB) | Preview |
Abstract
Colorectal malignancies are a leading cause of cancer-related death1 and have undergone extensive genomic study2,3. However, DNA mutations alone do not fully explain malignant transformation4,5,6,7. Here we investigate the co-evolution of the genome and epigenome of colorectal tumours at single-clone resolution using spatial multi-omic profiling of individual glands. We collected 1,370 samples from 30 primary cancers and 8 concomitant adenomas and generated 1,207 chromatin accessibility profiles, 527 whole genomes and 297 whole transcriptomes. We found positive selection for DNA mutations in chromatin modifier genes and recurrent somatic chromatin accessibility alterations, including in regulatory regions of cancer driver genes that were otherwise devoid of genetic mutations. Genome-wide alterations in accessibility for transcription factor binding involved CTCF, downregulation of interferon and increased accessibility for SOX and HOX transcription factor families, suggesting the involvement of developmental genes during tumourigenesis. Somatic chromatin accessibility alterations were heritable and distinguished adenomas from cancers. Mutational signature analysis showed that the epigenome in turn influences the accumulation of DNA mutations. This study provides a map of genetic and epigenetic tumour heterogeneity, with fundamental implications for understanding colorectal cancer biology.
Archive Staff Only
 |
View Item |
